Table of Content

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Global HER2 Breast Cancer Test Market Forecast
4.3. Global HER2 Breast Cancer Test Market Outlook
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity

5. Key Insights
5.1. Revenue Model
5.2. Pricing Analysis
5.3. COVID-19 Impact Analysis

6. Global HER2 Breast Cancer Test Market Analysis, by Test Type
6.1. Introduction
6.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Test Type
6.3. Global HER2 Breast Cancer Test Market Forecast, by Test Type
6.3.1. Immunohistochemistry (IHC)
6.3.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
6.4. Global HER2 Breast Cancer Test Market Analysis, by Test Type
6.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by Test Type

7. Global HER2 Breast Cancer Test Market Analysis, by End-user
7.1. Introduction
7.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by End-user
7.3. Global HER2 Breast Cancer Test Market Forecast, by End-user
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.4. Global HER2 Breast Cancer Test Market Analysis, by End-user
7.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by End-user

8. Global HER2 Breast Cancer Test Market Analysis, by Region
8.1. Introduction
8.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Region
8.3. Global HER2 Breast Cancer Test Market Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa

9. North America HER2 Breast Cancer Test Market Analysis
9.1. North America HER2 Breast Cancer Test Market Overview
9.2. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country
9.2.1. U.S.
9.2.2. Canada
9.3. North America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
9.4. North America HER2 Breast Cancer Test Market Forecast, by Test Type
9.4.1. Immunohistochemistry (IHC)
9.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
9.5. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
9.6. North America HER2 Breast Cancer Test Market Forecast, by End-user
9.6.1. Hospitals
9.6.2. Diagnostic Laboratories

10. Europe HER2 Breast Cancer Test Market Analysis
10.1. Europe HER2 Breast Cancer Test Market Overview
10.2. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type
10.4. Europe HER2 Breast Cancer Test Market Forecast, by Test Type
10.4.1. Immunohistochemistry (IHC)
10.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
10.5. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
10.6. Europe HER2 Breast Cancer Test Market Forecast, by End-user
10.6.1. Hospitals
10.6.2. Diagnostic Laboratories

11. Asia Pacific HER2 Breast Cancer Test Market Analysis
11.1. Asia Pacific HER2 Breast Cancer Test Market Overview
11.2. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.2.1. China
11.2.2. Japan
11.2.3. India
11.2.4. Australia & New Zealand
11.2.5. Rest of Asia Pacific
11.3. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
11.4. Asia Pacific HER2 Breast Cancer Test Market Forecast, by Test Type
11.4.1. Immunohistochemistry (IHC)
11.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
11.5. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user
11.6. Asia Pacific HER2 Breast Cancer Test Market Forecast, by End-user
11.6.1. Hospitals
11.6.2. Diagnostic Laboratories

12. Latin America HER2 Breast Cancer Test Market Analysis
12.1. Latin America HER2 Breast Cancer Test Market Overview
12.2. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region
12.2.1. Brazil
12.2.2. Mexico
12.2.3. Rest of Latin America
12.3. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
12.4. Latin America HER2 Breast Cancer Test Market Forecast, by Test Type
12.4.1. Immunohistochemistry (IHC)
12.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
12.5. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user
12.6. Latin America HER2 Breast Cancer Test Market Forecast, by End-user
12.6.1. Hospitals
12.6.2. Diagnostic Laboratories

13. Middle East & Africa HER2 Breast Cancer Test Market Analysis
13.1. Middle East & Africa HER2 Breast Cancer Test Market Overview
13.2. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.2.1. GCC Countries
13.2.2. South Africa
13.2.3. Rest of Middle East & Africa
13.3. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type
13.4. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by Test Type
13.4.1. Immunohistochemistry (IHC)
13.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
13.5. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
13.6. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by End-user
13.6.1. Hospitals

14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2019
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. BioGenex
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Agilent Technologies, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Leica Biosystems
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Roche
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Mylab Discovery Solutions Pvt. Ltd.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview



List of Figures

List of Figures

Figure 01: Global HER2 Breast Cancer Test Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global HER2 Breast Cancer Test Market Value Share, by Test Type (2020)

Figure 03: Global HER2 Breast Cancer Test Market Value Share, by End-user (2020)

Figure 04: Global HER2 Breast Cancer Test Market Value Share, by Region (2020)

Figure 05: Global HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 06: Global HER2 Breast Cancer Test Market Revenue (US$ Mn), by Immunohistochemistry (IHC), 2017–2031

Figure 07: Global HER2 Breast Cancer Test Market Revenue (US$ Mn), by Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH), 2017–2031

Figure 08: Global HER2 Breast Cancer Test Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 09: Global HER2 Breast Cancer Test Market Value Share Analysis, by Region, 2020 and 2031

Figure 10: Global HER2 Breast Cancer Test Market Attractiveness, by Region, 2021-2031

Figure 11: North America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 12: North America HER2 Breast Cancer Test Market Value Share (%), by Country, 2020 and 2031

Figure 13: North America HER2 Breast Cancer Test Market Attractiveness, by Country, 2021–2031

Figure 14: North America HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 15: North America HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021–2031

Figure 16: North America HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 17: North America HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021–2031

Figure 18: Europe HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 19: Europe HER2 Breast Cancer Test Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 20: Europe HER2 Breast Cancer Test Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 21: Europe HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 22 Europe HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021–2031

Figure 23: Europe HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 24: Europe HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021–2031

Figure 25: Asia Pacific HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 26: Asia Pacific HER2 Breast Cancer Test Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 27: Asia Pacific HER2 Breast Cancer Test Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 28: Asia Pacific HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 29: Asia Pacific HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021–2031

Figure 30: Asia Pacific HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 31: Asia Pacific HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021–2031

Figure 32: Latin America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 33: Latin America HER2 Breast Cancer Test Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 34: Latin America HER2 Breast Cancer Test Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 35: Latin America HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 36: Latin America HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021–2031

Figure 37: Latin America HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 38: Latin America HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021–2031

Figure 39: Middle East & Africa HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 40: Middle East & Africa HER2 Breast Cancer Test Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 41: Middle East & Africa HER2 Breast Cancer Test Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 42: Middle East & Africa HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 43: Middle East & Africa HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021–2031

Figure 44: Middle East & Africa HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 45: Middle East & Africa HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021–2031

List of Tables

List of Tables

Table 01: Global HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 02: Global HER2 Breast Cancer Test Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 03: North America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country, 2017–2031

Table 04: North America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 05: North America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Europe HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 07: Europe HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 08: Europe HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Asia Pacific HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Asia Pacific HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: Asia Pacific HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Latin America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Latin America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 14: Latin America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Middle East & Africa HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Middle East & Africa HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 17: Middle East & Africa HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031